ArticleOncotarget2015

Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.

Ji-Ae Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.